These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23051787)

  • 41. Pay for executives at private life sciences companies continues to steadily increase.
    Rychlik B
    Nat Biotechnol; 2011 Jan; 29(1):85-6. PubMed ID: 21221108
    [No Abstract]   [Full Text] [Related]  

  • 42. US life sciences gets the lion's share.
    Greenberg DS
    Lancet; 1999 Apr; 353(9162):1421. PubMed ID: 10227237
    [No Abstract]   [Full Text] [Related]  

  • 43. Aligning interests.
    Nat Biotechnol; 2008 Nov; 26(11):1199. PubMed ID: 18997739
    [No Abstract]   [Full Text] [Related]  

  • 44. Boosting biotech in Finland.
    Smaglik P
    Nature; 2004 Oct; 431(7011):1020-1. PubMed ID: 15496931
    [No Abstract]   [Full Text] [Related]  

  • 45. Research interactions between industry and academia: a corporate perspective.
    Citron P
    Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
    [No Abstract]   [Full Text] [Related]  

  • 46. The 1992 biotechnology agenda: a message for candidates Bush and Clinton.
    Duzan SA
    Healthspan; 1992 Sep; 9(8):12-5. PubMed ID: 10122052
    [No Abstract]   [Full Text] [Related]  

  • 47. Translational science: a view from a biotechnology investor.
    Klausner R
    Sci Transl Med; 2010 Jun; 2(34):34ed3. PubMed ID: 20519715
    [No Abstract]   [Full Text] [Related]  

  • 48. Prize drawback.
    Nature; 2013 Feb; 494(7438):402. PubMed ID: 23451352
    [No Abstract]   [Full Text] [Related]  

  • 49. Cell mates.
    Ruttimann J
    Nature; 2007 Nov; 450(7170):756-7. PubMed ID: 18172934
    [No Abstract]   [Full Text] [Related]  

  • 50. First Bush budget set to favour life sciences.
    Davis M
    Nature; 2001 Feb; 409(6823):969. PubMed ID: 11234034
    [No Abstract]   [Full Text] [Related]  

  • 51. Laying solid foundations for Europe.
    Mattaj IW; Tocchini-Valentini GP
    Nature; 2007 May; 447(7143):377-8. PubMed ID: 17522655
    [No Abstract]   [Full Text] [Related]  

  • 52. Fragmentation is industry obstacle in Europe.
    Mitchell P
    Nat Biotechnol; 2001 Jun; 19(6):494-5. PubMed ID: 11385414
    [No Abstract]   [Full Text] [Related]  

  • 53. Harvesting biotechnology.
    Dennis C; Byrne N
    Nature; 2004 Jun; 429(6991 Suppl):1. PubMed ID: 15175703
    [No Abstract]   [Full Text] [Related]  

  • 54. Dundee: discovering life sciences.
    Tasker H
    Drug Discov Today; 2006 May; 11(9-10):379-82. PubMed ID: 16635798
    [No Abstract]   [Full Text] [Related]  

  • 55. Transferring EU-funded biotechnology research to European bioindustry.
    Lawler C; van der Meer R; Viseur J
    Nat Biotechnol; 1998 Jun; 16(6):494. PubMed ID: 9624665
    [No Abstract]   [Full Text] [Related]  

  • 56. A new global strategy for the life sciences in Europe.
    van Dyck L
    EMBO Rep; 2005 Mar; 6(3):194-7. PubMed ID: 15741967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mile-high dreams.
    Cassiday L; Russo G
    Nature; 2010 Jul; 466(7302):146-7. PubMed ID: 20681064
    [No Abstract]   [Full Text] [Related]  

  • 58. Gore pledges support for bioscience.
    Wadman M
    Nature; 2000 Sep; 407(6801):118. PubMed ID: 11001023
    [No Abstract]   [Full Text] [Related]  

  • 59. US life scientists seek 15 per cent rise to NIH research funds.
    Wadman M
    Nature; 1999 Jan; 397(6717):284. PubMed ID: 9950418
    [No Abstract]   [Full Text] [Related]  

  • 60. US scientists seek more funds for high-tech equipment.
    Smaglik P
    Nature; 2000 Jul; 406(6792):112. PubMed ID: 10910321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.